ATNM: Introduction to Radiopharmaceuticals

By John Vandermosten, CFA NYSE: ATNM READ THE FULL ATNM NOTE Following our recent initiation of coverage for Actinium Pharmaceuticals, Inc. (NYSE: ATNM), this research note provides life sciences investors with an introduction to the radiopharmaceutical industry. We examine the science, clinical applications and manufacturing requirements shaping the sector, highlighting both its therapeutic